Skip to main content
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
8.91
+0.31 (3.60%)
At close: Feb 27, 2026, 4:00 PM EST
8.86
-0.05 (-0.56%)
After-hours: Feb 27, 2026, 7:59 PM EST

Vanda Pharmaceuticals Revenue

In the year 2025, Vanda Pharmaceuticals had annual revenue of $216.11M with 8.72% growth. Vanda Pharmaceuticals had revenue of $57.22M in the quarter ending December 31, 2025, with 7.58% growth.

Revenue (ttm)
$216.11M
Revenue Growth
+8.72%
P/S Ratio
2.44
Revenue / Employee
$405,450
Employees
533
Market Cap
526.65M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025216.11M17.33M8.72%
Dec 31, 2024198.77M6.13M3.18%
Dec 31, 2023192.64M-61.74M-24.27%
Dec 31, 2022254.38M-14.30M-5.32%
Dec 31, 2021268.68M20.51M8.27%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zevra Therapeutics 84.39M
Invivyd 50.04M
Prothena Corporation 9.68M
4D Molecular Therapeutics 120.00K
Lyell Immunopharma 41.00K
vTv Therapeutics 17.00K
Revenue Rankings

VNDA News

More News